$1.36 -0.03 (-2.16%) Verastem Inc - NASDAQ

Aug. 26, 2016 | 04:00 PM
Last Trade: 1.36
Trade Time: Aug 26 04:00 PM Eastern Daylight Time
Change: -0.03 (-2.16%)
Prev Close: 1.39
Open: 1.40
Bid: 1.36
Ask: 1.38
  1. No results found.
  1. 5 Deep Value or Net-Net Investment Ideas

    GuruFocus | Feb. 9, 2016 | 11:09AM EST
  2. Washington University Initiates Clinical Study of Verastem's VS-6063 in Combination with Merck's Pembrolizumab and Gemcitabine in Pancreatic Cancer

    Benzinga | Jan. 6, 2016 | 07:53AM EST
  3. Verastem Due Diligence: Cancels Phase II Study and Market Reacts - BrokerBank Securities

    Benzinga | Sep. 30, 2015 | 08:05AM EST
  4. Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

    Benzinga | Feb. 13, 2015 | 15:32PM EST
  5. 3 Biotech IPO's Debuting This Week

    Benzinga | Jan. 26, 2015 | 15:14PM EST
  6. 5 Biotech Secondaries Traders Are Watching

    Benzinga | Jan. 21, 2015 | 13:32PM EST
  7. US Stock Futures Surge Ahead Of Earnings

    Benzinga | Jan. 20, 2015 | 07:16AM EST
  8. Verastem Doses First Patient in Phase 1 Clinical Trial Evaluating VS-5584 in Combination with VS-6063 in Mesothelioma

    Benzinga | Jan. 20, 2015 | 07:05AM EST
  9. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  10. Verastem To Participate In Panel At The MassBio Patient Advocacy Summit

    Benzinga | Nov. 10, 2014 | 07:02AM EST
  11. UPDATE: Deutsche Bank Initiates Coverage On Verastem On Multiple Positive Factors

    Benzinga | May. 6, 2014 | 09:10AM EST
  12. Verastem Reports Data from Phase 1 Study of VS-6063 (defactinib) in Japanese Patients; Completes Full Enrollment and was "Well Tolerated" at Each Dosage Level

    Benzinga | Mar. 5, 2014 | 16:04PM EST
  13. Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718

    Benzinga | Feb. 25, 2014 | 07:07AM EST
  14. Verastem Initiates Phase 1 Trial of Dual mTOR/PI3K Inhibitor

    Benzinga | Dec. 10, 2013 | 07:16AM EST
  15. Verastem Begins Phase 2 Trial of Defatinib in Lunc Cancer

    Benzinga | Sep. 26, 2013 | 09:37AM EST
Trading Center